REGULATION OF 1,25-DIHYDROXYVITAMIN-D3 RECEPTOR GENE-EXPRESSION BY 1,25-DIHYDROXYVITAMIN-D3 IN THE PARATHYROID INVIVO

被引：159

作者：

NAVEHMANY, T

MARX, R

KESHET, E

PIKE, JW

SILVER, J

机构：

[1] HADASSAH UNIV HOSP, NEPHROL SERV, MINERAL METAB UNIT, IL-91120 JERUSALEM, ISRAEL

[2] TEXAS MED CTR, BAYLOR COLL MED, DEPT PEDIAT & ENDOCRINOL, HOUSTON, TX 77025 USA

[3] HADASSAH UNIV HOSP, DEPT VIROL, IL-91120 JERUSALEM, ISRAEL

来源：

JOURNAL OF CLINICAL INVESTIGATION | 1990年 / 86卷 / 06期

关键词：

Calcitonin transcription; Calcium; Flow cytometry; In situ hybridization;

D O I：

10.1172/JCI114931

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

1,25-Dihydroxyvitamin D3 (1,25(OH)2D3) dramatically decreases parathyroid hormone (PTH) gene transcription. We have now studied the effect of 1,25(OH)2D3 on the 1,25(OH)2D receptor (VDR) in the parathyroid in vivo. Rats were injected with 1,25(OH)2D3 and the parathyroid-thyroid tissue analyzed for PTHmRNA and VDRmRNA. 1,25(OH)2D3 (50 and 100 pmol ip) decreased PTHmRNA at 6 h with a maximum at 48 h (< 4% of basal), whereas VDRmRNA was increased only after 6 h with a 1.7-fold increase at 24 h. VDRmRNA levels peaked at 25 pmol 1,25(OH)2D3 with a twofold increase. Serum calcium did not affect VDRmRNA. Parathyroid VDRmRNA ran at 2.2 and 4.4 kb, whereas duodenum VDRmRNA had a single band, all of which increased after 1,25(OH)2D3. Weanling rats on a vitamin D-deficient diet for 3 wk had a more intense 2.2-kb transcript, whereas vitamin D-replete rats had a more intense 4.4-kb band. Dispersed parathyroid-thyroid cells were separated by a flow cytometry (FACS) into a parathyroid cell peak containing PTHmRNA and a second peak with cells positive for thyroglobulin mRNA and calcitonin mRNA. VDRmRNA was concentrated in the parathyroid cell peak. In situ hybridization of parathyroid-thyroid and duodenum for VDRmRNA showed its localization to the parathyroid cells and the duodenal mucosa. Therefore, the VDRmRNA in the parathyroid-thyroid tissue represents predominantly parathyroid cell and not C-cell VDRmRNA which is also a 1,25(OH)2D3 target organ. The increased VDR gene expression in the parathyroid cell would amplify the effect of 1,25(OH)2D3 to decrease PTH gene transcription.

引用

页码：1968 / 1975

页数：8

共 33 条

[21]

Pan P., Kaladhar B.R., Studzinski G., Pike J.W., Christakos S., Regulation of 1,25 dihydroxyvitamin D<sub>3</sub> receptor mRNA in human leukemia cells (HL-60), J. Bone Miner. Res., 4, (1989)

[22]

Naveh-Many T., Friedlaender M.M., Mayer H., Silver J., Calcium regulates parathyroid hormone messenger ribonucleic acid (mRNA), but not calcitonin mRNA in vivo in the rat. Dominant role of 1,25-dihydroxyvitamin D, Endocrinology, 125, pp. 275-280, (1989)

[23]

Baker A.R., McDonnel D.P., Hughes M., Crisp T.M., Mangelsdorf D.J., Haussler M.R., Pike J.W., Shine J., O'Malley B.W., Cloning and expression of full-length cDNA encoding human vitamin D receptor, Proc. Natl. Acad. Sci. USA, 85, pp. 3294-3298, (1988)

[24]

Krieg P.A., Melton D.A., In vitro RNA synthesis with SP6 RNA polymerase, Methods Enzymol., 155, pp. 397-415, (1987)

[25]

Brunius G., Technical aspects of the use of 3′,6′-diacetyl fluorescein for vital fluorescent staining of bacteria, Curr. Microbiol., 4, pp. 321-323, (1980)

[26]

Resnick M., Schuldiner S., Bercovier H., Bacterial membrane potential analyzed by spectrofluorocytometry, Curr. Microbiol., 12, pp. 183-186, (1985)

[27]

Naveh-Many T., Silver J., Regulation of parathyroid hormone gene expression by hypocalcemia, hypercalcemia and vitamin D in the rat, J. Clin. Invest., 86, pp. 1313-1319, (1990)

[28]

Hogan B., Constantini F., Lacy E., Manipulating the Mouse Embryo: A Laboratory Manual, (1986)

[29]

Keshet E., Polakiewicz R.D., Itin A., Ornoy A., Rosen H., Proenkephalin A is expressed in mesodermal lineages during organogenesis, EMBO (Eur. Mol. Biol. Organ.) J., 8, pp. 2917-2923, (1989)

[30]

Costa E.M., Feldman D., Measurement of 1,25-dihydroxyvitamin D<sub>3</sub> receptor turnover by dense amino acid labeling: Changes during receptor up-regulation by vitamin D metabolites, Endocrinology, 120, pp. 1173-1178, (1987)

← 1 2 3 4 →